Table 3.
Insecticidal activity of Cry1Ab, Vip3Aa20 and Cry1F against FAW at 120 h after treatment
Test protein | Protein concn. (ng/ml) | % Mortality (observed)a | % Mortality (expected) |
---|---|---|---|
Cry1Ab | 200 | 0.0 | N/A |
100 | 0.0 | ||
50 | 4.4 | ||
25 | 5.8 | ||
12.5 | 0.0 | ||
Vip3Aa20 | 400 | 60.9 | N/A |
200 | 51.5 | ||
100 | 44.1 | ||
50 | 14.5 | ||
25 | 5.8 | ||
Cry1F | 2,000 | 76.8 | N/A |
1,000 | 53.6 | ||
500 | 37.7 | ||
250 | 15.0 | ||
125 | 13.0 | ||
Test mixtureb | B | 91.3 | 90.9 |
B/2 | 85.5 | 77.5 | |
B/4 | 71.0 | 66.7 | |
B/8 | 47.1 | 31.5 | |
B/16 | 20.3 | 18.0 |
All data were corrected for buffer control mortality using Abbott’s formula.
The test mixture B was composed of 200, 400, and 2,000 ng/ml diet of Cry1Ab, Vip3Aa20, and Cry1F, respectively, as described in the Methods section.